News
CLPBY
6.66
-0.30%
-0.02
Weekly Report: what happened at CLPBY last week (0803-0807)?
Weekly Report · 6d ago
Coloplast Might Have Found Its Bottom
Seeking Alpha · 08/05 11:00
Weekly Report: what happened at CLPBY last week (0727-0731)?
Weekly Report · 08/03 09:24
This Value Investor Favors Global Stocks With Low -2-
Barron‘s · 07/30 05:00
This Value Investor Favors Global Stocks With Low Valuations, High Yields
Barron‘s · 07/30 05:00
Weekly Report: what happened at CLPBY last week (0720-0724)?
Weekly Report · 07/27 09:26
Weekly Report: what happened at CLPBY last week (0713-0717)?
Weekly Report · 07/20 09:25
Baird International And Global Growth Funds Q2 2026 Contributors And Detractors
Seeking Alpha · 07/13 19:33
Weekly Report: what happened at CLPBY last week (0706-0710)?
Weekly Report · 07/13 09:25
Weekly Report: what happened at CLPBY last week (0629-0703)?
Weekly Report · 07/06 09:26
Weekly Report: what happened at CLPBY last week (0622-0626)?
Weekly Report · 06/29 09:25
Weekly Report: what happened at CLPBY last week (0615-0619)?
Weekly Report · 06/22 09:28
Weekly Report: what happened at CLPBY last week (0608-0612)?
Weekly Report · 06/15 09:28
Weekly Report: what happened at CLPBY last week (0601-0605)?
Weekly Report · 06/08 09:26
Weekly Report: what happened at CLPBY last week (0525-0529)?
Weekly Report · 06/01 09:28
Weekly Report: what happened at CLPBY last week (0518-0522)?
Weekly Report · 05/25 09:29
Weekly Report: what happened at CLPBY last week (0511-0515)?
Weekly Report · 05/18 09:29
Coloplast: Went 'BUY' A Bit Early
Seeking Alpha · 05/16 14:37
Coloplast A/S reports Q2 results
Seeking Alpha · 05/12 18:52
Coloplast Q2 2026 Earnings Call: Complete Transcript
Benzinga · 05/12 10:07
More
Webull provides a variety of real-time CLPBY stock news. You can receive the latest news about Coloplast As Drc through multiple platforms. This information may help you make smarter investment decisions.
About CLPBY
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.